Association of Hypoalbuminemia with Severe Anemia in Patients with Diabetic Nephrosclerosis

REFERENCES

• The statistic analyzed commission of Japan Society for Dialysis Therapy: An overview of dialysis treatment in Japan (as of December 31, 2008): 12.
   Google Scholar
• Sasatomi Y, Kaneoka H, Abe Y, . Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus. Clin Exp Nephrol. 2009;13:473–479.
   PubMed Web of Science ®Google Scholar
• Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426–430.
   PubMed Web of Science ®Google Scholar
• Keane WF, Brenner BM, de Zeeuw D, . The risk of developing end stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study. Kidney Int. 2003;63:1499–1507.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75.
   PubMed Web of Science ®Google Scholar
• Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001;60:277–283.
   PubMed Web of Science ®Google Scholar
• Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62:202–228.
   Web of Science ®Google Scholar
• Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–1151.
   PubMed Web of Science ®Google Scholar
• Shestakova MV, Chugunova LA, Shamkhalova MSh, Dirochka IuA, Dedov II. Diabetic nephropathy: Risk factors of rapid progression of renal failure. Ter Arkh. 1999;71:45–49.
   PubMed Web of Science ®Google Scholar
• Ravanan R, Spiro JR, Mathieson PW, . Impact of diabetes on hemoglobin levels in renal disease. Diabetologia 2007;50:26–31.
   PubMed Web of Science ®Google Scholar
• Li Vecchi M, Fuiano G, Francesco M, . Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency. Nephron Clin Pract. 2007;105:c62–c67.
   PubMedGoogle Scholar
• Thomas MC, Tsalamandris C, Macisaac R, Jerums G. Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia. Diabet Med. 2006;23:502–509.
   PubMed Web of Science ®Google Scholar
• Katavetin P, Miyata T, Inagi R, . High glucose blunts VEGF response to hypoxia via the oxidative stress-regulated HIF-HRE pathway. J Am Soc Nephrol. 2006;17:1405–1413.
   PubMed Web of Science ®Google Scholar
• Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diab Care. 2001;24:495–499.
   PubMed Web of Science ®Google Scholar
• Bayes B, Serra A, Junca J, Lauzurica R. Successful treatment of anemia of nephrotic syndrome with recombinant human erythropoietin. Nephrol Dial Transplant. 1998;13:1894–1895.
   PubMed Web of Science ®Google Scholar
• Lorber D, Reddan D. Clinical characteristics of chronic kidney disease patients with and without diabetes: A subanalysis of the PAERI study. Clin Nephrol. 2006;66:11–16.
   PubMed Web of Science ®Google Scholar
• Ishimura E, Nishizawa Y, Okuno S, . Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol. 1998;11:83–86.
   PubMed Web of Science ®Google Scholar
• Furuta T, Saito T, Ootaka T, . The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis. 1993;21:480–485.
   PubMed Web of Science ®Google Scholar
• Sasatomi Y, Sato H, Chiba Y, . Prognostic factors for renal amyloidosis: A clinicopathological study using cluster analysis. Int Med. 2007;46:213–219.
   PubMed Web of Science ®Google Scholar
• Hishida A, Yokoyama H, Tomino Y, . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. Epub 2009;53:982–992.
   PubMed Web of Science ®Google Scholar
• Kazmi WH, Kausz AT, Khan S, . Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803–812.
   PubMed Web of Science ®Google Scholar
• Vlagopoulos PT, Tighiouart H, Weiner DE, . Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: The impact of chronic kidney disease. J Am Soc Nephrol. 2005;16:3403–3410.
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A. The cardio-renal anemia syndrome: Does it exist? Nephrol Dial Transplant. 2003;18(Suppl. 8):S7–S12.
   PubMedGoogle Scholar
• Ritz E, Laville M, Bilous RW, . Anemia correction in diabetes study investigators. Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the Anemia Correction in Diabetes (ACORD) Study. Am J Kidney Dis. 2007;49:194–207.
   PubMed Web of Science ®Google Scholar
• Singh AK, Szczech L, Tang KL, . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–2098.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Burdmann EA, Chen CY, . A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997;77:176–185.
   PubMed Web of Science ®Google Scholar
• Lee H, Manns B, Taub K, . Cost analysis of ongoing care of patients with end stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40:611–622.
   PubMed Web of Science ®Google Scholar
• Nakao T, Kanazawa Y, Matsumoto H, Okada T, Nagaoka Y. Effective dietary protein restriction in the treatment of diabetic nephropathy. Nephrol Front. 2005;4:166–167.
   Google Scholar
• Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: A meta-analysis of randomized controlled trial. Am J Clin Nut. 2008;88:660–666.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2009. Diab Care. 2009;32(Suppl. 1):s13–s61.
   PubMed Web of Science ®Google Scholar
• Nakao T, Okada T. Meaning and problems in low-protein diet for renal failure. Jpn J Soc Int Med. 2006;95:368–373.
   PubMedGoogle Scholar
• Stenvinkel P, Heimbürger O, Wang T, Elinder C-G, Bergström J, Lindholm B. A syndrome of malnutrition, inflammation and atherosclerosis(MIA) is associated with elevated serum hyaluronan and increased mortality in chronic renal failure (CRF). J Am Soc Nephrol. 1999;10:182A.
   Google Scholar
• Kato A. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome. Future Cardiol. 2010;6:769–771.
   PubMedGoogle Scholar